BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Blackard JT, Kong L, Rouster SD, Karns R, Horn PS, Kottilil S, Shata MT, Sherman KE. CCR5 receptor antagonism inhibits hepatitis C virus (HCV) replication in vitro. PLoS One 2019;14:e0224523. [PMID: 31661521 DOI: 10.1371/journal.pone.0224523] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhou L, Liu Z, Zheng Z, Yao D, Zhao Y, Chen X, Zhang Y, Aweya JJ. The CCR1 and CCR5 C–C chemokine receptors in Penaeus vannamei are annexed by bacteria to attenuate shrimp survival. Developmental & Comparative Immunology 2022. [DOI: 10.1016/j.dci.2022.104561] [Reference Citation Analysis]
2 Mladinich MC, Conde JN, Schutt WR, Sohn SY, Mackow ER. Blockade of Autocrine CCL5 Responses Inhibits Zika Virus Persistence and Spread in Human Brain Microvascular Endothelial Cells. mBio 2021;12:e0196221. [PMID: 34399621 DOI: 10.1128/mBio.01962-21] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Kukla DA, Khetani SR. Bioengineered Liver Models for Investigating Disease Pathogenesis and Regenerative Medicine. Semin Liver Dis 2021;41:368-92. [PMID: 34139785 DOI: 10.1055/s-0041-1731016] [Reference Citation Analysis]
4 Familiar-Macedo D, Amancio Paiva I, Badolato-Corrêa da Silva J, de Carvalho FR, Dias HG, Pauvolid-Corrêa A, Dos Santos CF, Gandini M, Silva AA, Baeta Cavalcanti SM, Artimos de Oliveira S, Artimos de Oliveira Vianna R, Leal de Azeredo E, Grifoni A, Sette A, Weiskopf D, Araújo Cardoso CA, de-Oliveira-Pinto LM. Evaluation of the Expression of CCR5 and CX3CR1 Receptors and Correlation with the Functionality of T Cells in Women infected with ZIKV during Pregnancy. Viruses 2021;13:191. [PMID: 33525328 DOI: 10.3390/v13020191] [Reference Citation Analysis]
5 Peters MG, Kottilil S, Terrault N, Amara D, Husson J, Huprikar S, Florman S, Sulkowski MS, Durand CM, Luetkemeyer AF, Rogers R, Grab J, Haydel B, Blumberg E, Dove L, Emond J, Olthoff K, Smith C, Fishbein T, Masur H, Stock PG. Retrospective-prospective study of safety and efficacy of sofosbuvir-based direct-acting antivirals in HIV/HCV-coinfected participants with decompensated liver disease pre- or post-liver transplant. Am J Transplant. 2020;. [PMID: 33277801 DOI: 10.1111/ajt.16427] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
6 Smith NC, Goulart C, Hayward JA, Kupz A, Miller CM, van Dooren GG. Control of human toxoplasmosis. Int J Parasitol 2021;51:95-121. [PMID: 33347832 DOI: 10.1016/j.ijpara.2020.11.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
7 Baruah V, Tiwari D, Hazam RK, Bose M, Bujarbaruah D, Saikia AK, Kar P, Dutta S, Bose S. Prognostic, clinical, and therapeutic importance of RANTES-CCR5 axis in hepatitis A infection: A multiapproach study. J Med Virol 2021;93:3656-65. [PMID: 32975838 DOI: 10.1002/jmv.26557] [Reference Citation Analysis]
8 Apaza Ticona L, Bermejo P, Guerra JA, Abad MJ, Beltrán M, Martín Lázaro R, Alcamí J, Bedoya LM. Ethanolic extract of Artemisia campestris subsp. glutinosa (Besser) Batt. inhibits HIV-1 replication in vitro through the activity of terpenes and flavonoids on viral entry and NF-κB pathway. J Ethnopharmacol 2020;263:113163. [PMID: 32758575 DOI: 10.1016/j.jep.2020.113163] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Ellwanger JH, Kulmann-Leal B, Kaminski VL, Rodrigues AG, Bragatte MAS, Chies JAB. Beyond HIV infection: Neglected and varied impacts of CCR5 and CCR5Δ32 on viral diseases. Virus Res 2020;286:198040. [PMID: 32479976 DOI: 10.1016/j.virusres.2020.198040] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]